C
Canary Medical
Vancouver-based medical data firm
About Canary Medical
Canary Medical is a pioneering medical data company focused on improving healthcare outcomes through the use of implantable medical devices. Operating in the healthcare technology market, Canary Medical serves patients, healthcare providers, and medical institutions by providing advanced solutions that integrate with standard medical devices to collect and analyze data on patient mobility and health conditions.
The company's core product, Canturio™, is a SMART medical device designed to give medical implants a 'voice' by enabling them to communicate objective data remotely. This data is then aggregated, analyzed, and made accessible through Canary's wholly-owned subsidiary, Summatix™, which specializes in data management. This platform ensures that the raw sensor data collected from implants is clinically relevant and available to both patients and healthcare providers.
Canary Medical's business model revolves around the development, manufacturing, and sale of these innovative medical devices, as well as the provision of data management services. Revenue is generated through the sale of Canturio™ devices and subscription fees for data management services provided by Summatix™.
The company operates in a highly regulated market and has secured over 80 granted and pending patents, underscoring its commitment to innovation and regulatory compliance. Canary Medical's first product, the Canturio™ TE, is a modified tibial extension for use with Zimmer Persona prosthetic knee joints and has been designated a Breakthrough Device by the FDA.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 67
- Open positions
- None listed
- Dealroom signal
- 70.8/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Rehabilitation, Wearable, Hard Tech, DT and LS, science-based
- Technology
- Hardware, Deep Tech, Connected Device, IoT InternetOfThings
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES CEquity / VC | Oct 2022 | $0 | — | Undisclosed | — |
| DEBT✓Debt | Feb 2022 | $10M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Canary Medical is 1.8K monthly website visits, down 28% over the last three months. Canary Medical's team grew 6.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Canary Medical in the Vancouver ecosystem
The Canary Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US National Science Foundation
Series A4 investors entered at this stage
Relentless Pursuit Partners
BioScience Managers Limited
GF Securities- GFGlobal health sciences venture fund
Series B and later3 investors entered at this stage
Standard Treasury
Horizon Technology Finance Corporation
Silicon Valley Bank
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Canary Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Canary Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









